-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BgYbTdJpLqzMpma+fQnIr+2TwNsVSccK1T3ZwJGM1Rfnso7QNm8RppZuofOAW+YV PMSjrhoHZHvFsQuKJMnFnw== 0001144204-09-059228.txt : 20091116 0001144204-09-059228.hdr.sgml : 20091116 20091116063616 ACCESSION NUMBER: 0001144204-09-059228 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090930 FILED AS OF DATE: 20091116 DATE AS OF CHANGE: 20091116 EFFECTIVENESS DATE: 20091116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genmed Holding Corp CENTRAL INDEX KEY: 0001061688 STANDARD INDUSTRIAL CLASSIFICATION: COMMERCIAL PRINTING [2750] IRS NUMBER: 880390828 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-26607 FILM NUMBER: 091183617 BUSINESS ADDRESS: STREET 1: BANK OF AMERICA BUILDING STREET 2: 980 POST ROAD EAST, 2ND FLOOR CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 203-401-8089 MAIL ADDRESS: STREET 1: BANK OF AMERICA BUILDING STREET 2: 980 POST ROAD EAST, 2ND FLOOR CITY: WESTPORT STATE: CT ZIP: 06880 FORMER COMPANY: FORMER CONFORMED NAME: SATELLITE NEWSPAPERS CORP DATE OF NAME CHANGE: 20060404 FORMER COMPANY: FORMER CONFORMED NAME: SATELLITE ENTERPRISES CORP DATE OF NAME CHANGE: 20020903 FORMER COMPANY: FORMER CONFORMED NAME: GREENVOLT POWER CORP DATE OF NAME CHANGE: 20000927 NT 10-Q 1 v166462_nt10q.htm Unassociated Document

United States
Securities and Exchange Commission
Washington, D.C. 20549

Form 12b-25

NOTIFICATION OF LATE FILING


 
(Check one): 
o Form 10-K
 o Form 20-F  o Form 11-K x Form 10-Q o Form N-SAR  
  o Form N-CSR          
             
  For Period Ended: September 30, 2009        
             
  o Transition Report on Form 10-K        
  o Transition Report on Form 20-F        
  o Transition Report on Form 11-K        
  o Transition Report on Form 10-Q        
  o Transition Report on Form N-SAR        
 
For the Transition Period Ended:  N/A

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:  N/A
 
Part I - Registrant Information

Full Name of Registrant: Genmed Holding Corp.

Former Name if Applicable: N/A

Address of Principal Executive Office (Street and Number): Rontgenlaan 27, Zoetermeer, Holland 2719DX

Part II - Rules 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate).

 
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
 
 
x (b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR or Form N-CSR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     
 
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 Part III – Narrative
 
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The registrant was unable, without unreasonable effort and expense, to prepare its accounting records and schedules in sufficient time to allow its accountants to complete its review of the registrant for the period ended September 30, 2009, before the required filing date for its Form 10-Q.


 Part IV - Other Information
 
(1)
Name and telephone number of person to contact in regard to this notification
 
Randy Hibma
  
(011) 31
  
793-630-129
(Name)
  
(Area Code)
  
(Telephone Number)
 
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s).    Yes x     No o

 
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?    Yes o     No x
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
 
 
Genmed Holding Corp.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: November 16, 2009
By:
/s/ Randy Hibma
  
   
Randy Hibma, Chief Financial Officer and Vice President
  
       
       

ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
 


 -----END PRIVACY-ENHANCED MESSAGE-----